… patients receiving DOACs increased 40-fold [Citation67]. Thus, DDIs with NOACs in elderly
patients … summarize the current state of knowledge about DDIs of NOACs in elderly patients. …

… in these patients, render the use of anticoagulants quite challenging. Novel oral anticoagulants
(… Elderly patients with AF and VTE are at elevated risk of thromboembolic events and …

… In order to optimize both safety and efficacy of the new oral anticoagulants in elderly patients
with renal impairment, and to validate guideline recommendations, randomized clinical …

… , elderly patients with AF usually have more concomitant conditions that affect compliance and
adherence to anticoagulant therapy… among elderly AF patients receiving anticoagulants in …

… Optimizing the use of oral anticoagulants should make warfarin a safer therapy and encourage
more widespread use of this highly effective medication among the many elderly patients …

… It is unclear whether elderly patients established on direct oral anticoagulants (DOACs) …
We assessed DOAC exposure and factors affecting it in a real-world elderly cohort of patients. …

… of recurrent VTE was conserved both in the elderly subgroup and in the subgroup with …
with warfarin in elderly patients. In elderly patients and patients with impaired renal function, …

… , has contributed to the underuse of oral anticoagulants in the elderly. Also, the narrow …
vitamin K antagonist oral anticoagulants (NOACs). Non-vitamin K oral antagonists (apixaban…

… elderly patients with NVAF treated with oral anticoagulants in … patients with a high hemorrhagic
risk and DOACs in patients … of patients had a poor adherence to anticoagulant treatment. …

… Oral anticoagulants (OACs) are the cornerstone of treatment to reduce the associated risk
… ) have shown that non-vitamin K antagonist oral anticoagulants (NOACs) are non-inferior to …